[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Pembrolizumab Market Research Report 2016

November 2016 | 108 pages | ID: G67AE89AD99EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Production, means the output of Pembrolizumab

Revenue, means the sales value of Pembrolizumab

This report studies Pembrolizumab in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
  • Merck & Co., Inc.
  • Novartis AG
  • Onxeo SA
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Taiwan Liposome Company, Ltd.
  • Tiziana Life Sciences Plc
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Pembrolizumab in these regions, from 2011 to 2021 (forecast), like
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on consumption, market share and growth rate of Pembrolizumab in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Global Pembrolizumab Market Research Report 2016

1 PEMBROLIZUMAB MARKET OVERVIEW

1.1 Product Overview and Scope of Pembrolizumab
1.2 Pembrolizumab Segment by Type
  1.2.1 Global Production Market Share of Pembrolizumab by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Pembrolizumab Segment by Application
  1.3.1 Pembrolizumab Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Pembrolizumab Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Pembrolizumab (2011-2021)

2 GLOBAL PEMBROLIZUMAB MARKET COMPETITION BY MANUFACTURERS

2.1 Global Pembrolizumab Production and Share by Manufacturers (2015 and 2016)
2.2 Global Pembrolizumab Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Pembrolizumab Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Pembrolizumab Manufacturing Base Distribution, Sales Area and Product Type
2.5 Pembrolizumab Market Competitive Situation and Trends
  2.5.1 Pembrolizumab Market Concentration Rate
  2.5.2 Pembrolizumab Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL PEMBROLIZUMAB PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Pembrolizumab Production and Market Share by Region (2011-2016)
3.2 Global Pembrolizumab Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL PEMBROLIZUMAB SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Pembrolizumab Consumption by Regions (2011-2016)
4.2 North America Pembrolizumab Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Pembrolizumab Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Pembrolizumab Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Pembrolizumab Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Pembrolizumab Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Pembrolizumab Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL PEMBROLIZUMAB PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Pembrolizumab Production and Market Share by Type (2011-2016)
5.2 Global Pembrolizumab Revenue and Market Share by Type (2011-2016)
5.3 Global Pembrolizumab Price by Type (2011-2016)
5.4 Global Pembrolizumab Production Growth by Type (2011-2016)

6 GLOBAL PEMBROLIZUMAB MARKET ANALYSIS BY APPLICATION

6.1 Global Pembrolizumab Consumption and Market Share by Application (2011-2016)
6.2 Global Pembrolizumab Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL PEMBROLIZUMAB MANUFACTURERS PROFILES/ANALYSIS

7.1 Merck & Co., Inc.
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Pembrolizumab Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Merck & Co., Inc. Pembrolizumab Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Novartis AG
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Pembrolizumab Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Novartis AG Pembrolizumab Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Onxeo SA
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Pembrolizumab Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Onxeo SA Pembrolizumab Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Sumitomo Dainippon Pharma Co., Ltd.
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Pembrolizumab Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Sumitomo Dainippon Pharma Co., Ltd. Pembrolizumab Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Taiwan Liposome Company, Ltd.
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Pembrolizumab Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Taiwan Liposome Company, Ltd. Pembrolizumab Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Tiziana Life Sciences Plc
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Pembrolizumab Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Tiziana Life Sciences Plc Pembrolizumab Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview

8 PEMBROLIZUMAB MANUFACTURING COST ANALYSIS

8.1 Pembrolizumab Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Pembrolizumab

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Pembrolizumab Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Pembrolizumab Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL PEMBROLIZUMAB MARKET FORECAST (2016-2021)

12.1 Global Pembrolizumab Production, Revenue Forecast (2016-2021)
12.2 Global Pembrolizumab Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Pembrolizumab Production Forecast by Type (2016-2021)
12.4 Global Pembrolizumab Consumption Forecast by Application (2016-2021)
12.5 Pembrolizumab Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Pembrolizumab
Figure Global Production Market Share of Pembrolizumab by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Pembrolizumab Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Pembrolizumab Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Pembrolizumab Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Pembrolizumab Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Pembrolizumab Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Pembrolizumab Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Pembrolizumab Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Pembrolizumab Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Pembrolizumab Production of Key Manufacturers (2015 and 2016)
Table Global Pembrolizumab Production Share by Manufacturers (2015 and 2016)
Figure 2015 Pembrolizumab Production Share by Manufacturers
Figure 2016 Pembrolizumab Production Share by Manufacturers
Table Global Pembrolizumab Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Pembrolizumab Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Pembrolizumab Revenue Share by Manufacturers
Table 2016 Global Pembrolizumab Revenue Share by Manufacturers
Table Global Market Pembrolizumab Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Pembrolizumab Average Price of Key Manufacturers in 2015
Table Manufacturers Pembrolizumab Manufacturing Base Distribution and Sales Area
Table Manufacturers Pembrolizumab Product Type
Figure Pembrolizumab Market Share of Top 3 Manufacturers
Figure Pembrolizumab Market Share of Top 5 Manufacturers
Table Global Pembrolizumab Production by Regions (2011-2016)
Figure Global Pembrolizumab Production and Market Share by Regions (2011-2016)
Figure Global Pembrolizumab Production Market Share by Regions (2011-2016)
Figure 2015 Global Pembrolizumab Production Market Share by Regions
Table Global Pembrolizumab Revenue by Regions (2011-2016)
Table Global Pembrolizumab Revenue Market Share by Regions (2011-2016)
Table 2015 Global Pembrolizumab Revenue Market Share by Regions
Table Global Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
Table China Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
Table India Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Pembrolizumab Consumption Market by Regions (2011-2016)
Table Global Pembrolizumab Consumption Market Share by Regions (2011-2016)
Figure Global Pembrolizumab Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Pembrolizumab Consumption Market Share by Regions
Table North America Pembrolizumab Production, Consumption, Import & Export (2011-2016)
Table Europe Pembrolizumab Production, Consumption, Import & Export (2011-2016)
Table China Pembrolizumab Production, Consumption, Import & Export (2011-2016)
Table Japan Pembrolizumab Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Pembrolizumab Production, Consumption, Import & Export (2011-2016)
Table India Pembrolizumab Production, Consumption, Import & Export (2011-2016)
Table Global Pembrolizumab Production by Type (2011-2016)
Table Global Pembrolizumab Production Share by Type (2011-2016)
Figure Production Market Share of Pembrolizumab by Type (2011-2016)
Figure 2015 Production Market Share of Pembrolizumab by Type
Table Global Pembrolizumab Revenue by Type (2011-2016)
Table Global Pembrolizumab Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Pembrolizumab by Type (2011-2016)
Figure 2015 Revenue Market Share of Pembrolizumab by Type
Table Global Pembrolizumab Price by Type (2011-2016)
Figure Global Pembrolizumab Production Growth by Type (2011-2016)
Table Global Pembrolizumab Consumption by Application (2011-2016)
Table Global Pembrolizumab Consumption Market Share by Application (2011-2016)
Figure Global Pembrolizumab Consumption Market Share by Application in 2015
Table Global Pembrolizumab Consumption Growth Rate by Application (2011-2016)
Figure Global Pembrolizumab Consumption Growth Rate by Application (2011-2016)
Table Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co., Inc. Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co., Inc. Pembrolizumab Market Share (2011-2016)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG Pembrolizumab Market Share (2011-2016)
Table Onxeo SA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Onxeo SA Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
Figure Onxeo SA Pembrolizumab Market Share (2011-2016)
Table Sumitomo Dainippon Pharma Co., Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sumitomo Dainippon Pharma Co., Ltd. Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sumitomo Dainippon Pharma Co., Ltd. Pembrolizumab Market Share (2011-2016)
Table Taiwan Liposome Company, Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Taiwan Liposome Company, Ltd. Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
Figure Taiwan Liposome Company, Ltd. Pembrolizumab Market Share (2011-2016)
Table Tiziana Life Sciences Plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tiziana Life Sciences Plc Pembrolizumab Production, Revenue, Price and Gross Margin (2011-2016)
Figure Tiziana Life Sciences Plc Pembrolizumab Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pembrolizumab
Figure Manufacturing Process Analysis of Pembrolizumab
Figure Pembrolizumab Industrial Chain Analysis
Table Raw Materials Sources of Pembrolizumab Major Manufacturers in 2015
Table Major Buyers of Pembrolizumab
Table Distributors/Traders List
Figure Global Pembrolizumab Production and Growth Rate Forecast (2016-2021)
Figure Global Pembrolizumab Revenue and Growth Rate Forecast (2016-2021)
Table Global Pembrolizumab Production Forecast by Regions (2016-2021)
Table Global Pembrolizumab Consumption Forecast by Regions (2016-2021)
Table Global Pembrolizumab Production Forecast by Type (2016-2021)
Table Global Pembrolizumab Consumption Forecast by Application (2016-2021)


More Publications